#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4375425	A	Oral bioavailability in mouse at 5 mg/kg by LC-MS analysis	Mus musculus	2		organism-based format	Scientific Literature
2.	ALA4375430	A	AUC in mouse at 5 mg/kg, ip by LC-MS analysis	Mus musculus	2		organism-based format	Scientific Literature
3.	ALA4375432	A	AUC in mouse at 5 mg/kg, po by LC-MS analysis	Mus musculus	2		organism-based format	Scientific Literature
4.	ALA4375433	A	Tmax in mouse at 5 mg/kg, po by LC-MS analysis	Mus musculus	2		organism-based format	Scientific Literature
5.	ALA4375434	A	Tmax in mouse at 5 mg/kg, ip by LC-MS analysis	Mus musculus	2		organism-based format	Scientific Literature
6.	ALA4375435	A	Cmax in mouse at 5 mg/kg, po by LC-MS analysis	Mus musculus	2		organism-based format	Scientific Literature
7.	ALA4375436	A	Cmax in mouse at 5 mg/kg, ip by LC-MS analysis	Mus musculus	2		organism-based format	Scientific Literature
8.	ALA4375439	B	Inhibition of mouse slc26a3 expressed in FRT cells co-expressing EYFP-H148Q/I152L/F46L assessed as reduction in protein-mediated chloride/iodide exchange preincubated for 10 mins followed by NaI-substituted PBS addition and measured by YFP-based fluorescence assay	Mus musculus	45		cell-based format	Scientific Literature
9.	ALA4375444	A	Time at which serum concentration stays above in vitro IC50 for inhibition of mouse slc26a3 expressed in FRT cells in mouse at 5 mg/kg, po or ip by LC-MS analysis	Mus musculus	1		organism-based format	Scientific Literature
10.	ALA5053125	B	Inhibition of mouse Slc26a3 transfected in rat FRT cells preincubated with forskolin, 8-Br-cGMP and PMA and measured by fluorescence assay	Mus musculus	51		cell-based format	Patent Bioactivity Data
11.	ALA5053126	B	Inhibition of mouse Slc26a3 transfected in rat FRT cells at 10 uM preincubated with forskolin, 8-Br-cGMP and PMA and measured by fluorescence assay relative to control	Mus musculus	1		cell-based format	Patent Bioactivity Data
12.	ALA5053127	B	Inhibition of Slc26a3-mediated HCO3- influx/Cl efflux in rat FRT cells measured by fluorescence assay	Rattus norvegicus	1		cell-based format	Patent Bioactivity Data
13.	ALA5053128	B	Inhibition of Slc26a3-mediated Cl-/SCN- exchange in rat FRT cells measured by fluorescence assay	Rattus norvegicus	1		cell-based format	Patent Bioactivity Data
14.	ALA5053129	B	Inhibition of Slc26a3-mediated Cl-/ I- exchange in rat FRT cells assessed as half-life measured by fluorescence assay	Rattus norvegicus	1		cell-based format	Patent Bioactivity Data
15.	ALA5053130	B	Inhibition of SLC26A3-mediated Cl-/ I- exchange in human HEK293 cells measured by fluorescence assay	Homo sapiens	1		cell-based format	Patent Bioactivity Data
16.	ALA5053131	B	Inhibition of mouse Slc26a4-mediated Cl-/ I- exchange at 10 uM measured by cell-based fluorescence assay	Mus musculus	1		cell-based format	Patent Bioactivity Data
17.	ALA5053132	B	Inhibition of mouse Slc26a6-mediated Cl-/ I- exchange at 10 uM measured by cell-based fluorescence assay	Mus musculus	1		cell-based format	Patent Bioactivity Data
18.	ALA5053133	B	Inhibition of mouse Slc26a9-mediated Cl-/ I- exchange at 10 uM measured by cell-based fluorescence assay	Mus musculus	1		cell-based format	Patent Bioactivity Data
19.	ALA5053134	B	Inhibition of mouse CFTR at 10 uM measured by cell-based fluorescence assay	Mus musculus	1		cell-based format	Patent Bioactivity Data
20.	ALA5053135	B	Inhibition of mouse TMEM16A at 10 uM measured by cell-based fluorescence assay	Mus musculus	1		cell-based format	Patent Bioactivity Data